NCT07358585 2026-01-22
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
Shanghai Henlius Biotech
Phase 1/2 Not yet recruiting
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Henlius Biotech